13F Pro Quality Score

16.3/100

Rank #2,841 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

NTRB Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for NutriBand Inc. (NTRB), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NTRB at 16.3/100 on a 32-signal composite quality model, placing it at rank #2,841 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), NutriBand Inc. reports quarterly revenue of $437.5K, net income of $-880.6K. Top institutional holders of NTRB by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, CITADEL ADVISORS, based on the most recent SEC filings. NTRB trades on the Nasdaq exchange and files with the SEC under CIK 1676047. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NTRB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NutriBand Inc. directly from SEC EDGAR. NutriBand Inc.'s 13F Pro composite quality score has ranged between 10 and 16 since 2026, currently 16.3 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$437.5K

Net Income

Q2 2026

$-880.6K

ROIC

Q2 2026

-66.9%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-4.8% YoY
$2.0MFY 2026
FY23 $2.1MFY24 $2.1MFY25 $2.1MFY26 $2.0M

Net Income

+21.5% YoY
$-8.2MFY 2026
FY23 $-4.5MFY24 $-5.5MFY25 $-10.5MFY26 $-8.2M

Operating Income

+19.1% YoY
$-8.3MFY 2026
FY23 $-4.5MFY24 $-4.9MFY25 $-10.3MFY26 $-8.3M

EPS (Diluted)

-160.6% YoY
$-2.58FY 2026
FY23 $-0.53FY24 $-0.69FY25 $-0.99FY26 $-2.58

Total Assets

+1.0% YoY
$7.5MFY 2026
FY23 $9.5MFY24 $7.5MFY25 $7.5MFY26 $7.5M

Total Debt

FY 2026
FY23 FY24 $2.0MFY25 FY26

Op. Cash Flow

-11.0% YoY
$-5.1MFY 2026
FY23 $-3.0MFY24 $-3.5MFY25 $-4.6MFY26 $-5.1M

Free Cash Flow

-8.9% YoY
$-5.1MFY 2026
FY23 $-3.1MFY24 $-3.6MFY25 $-4.7MFY26 $-5.1M

Get alerted when NTRB's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NutriBand Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of NTRB

Put NTRB on your watchlist

Track score changes the day NutriBand Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is NTRB a good stock to buy?

13F Pro's AI-powered analysis of NutriBand Inc. (NTRB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NTRB are available on the NTRB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NTRB is classified as a small company.

Which hedge funds own NTRB?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NTRB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NutriBand Inc.'s investment landscape.